Alcon
NYSE:ALCAlcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Binovi Technologies
OTCMKTS:BNVIFBinovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company's products under development includes Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.
Cann American
CNSX:CNNACannaOne Technologies Inc., a software development and technology company, develops and markets online e-commerce marketplace solution for the cannabis industry in Canada. It provides BloomKit, a software suite that delivers an online toolkit for various applications for companies in the cannabis sector; and BWell, which uses BloomKit to facilitate the sale of premium CBD products on its online marketplace. The company also operates Primo, a review driven marketplace that show a dispensary directory, brand pages, visual product attributes, and multi-varied cannabis centric reviews. CannaOne Technologies Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada.
Physicians Realty Trust
NYSE:DOCPhysicians Realty Trust is a self-managed health care real estate company organized to acquire, selectively develop, own, and manage health care properties that are leased to physicians, hospitals, and health care delivery systems. The Company invests in real estate that is integral to providing high quality health care. The Company conducts its business through an UPREIT structure in which its properties are owned by Physicians Realty L.P., a Delaware limited partnership (the operating partnership), directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the operating partnership and, as of June 30, 2023, owned approximately 96.0% of OP Units.